Skip to main content
User account menu
Log in
X
Main navigation
About
Advisory Boards
Leadership
Steering Committee
News & Announcements
Messages from Our Leaders and Colleagues
Press Releases
HIV in the News
Events & Training
Grants & Funding
People
Email Groups
Publications
Resources
Search
Home
News & Announcements
HIV / AIDS in the News
Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries - PR Newswire
Wednesday, October 2 2024 - 10:34
Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries - StockTitan
Wednesday, October 2 2024 - 10:34
Rise in new HIV diagnoses in England puts 2030 zero transmission target ‘at risk’ - PinkNews
Wednesday, October 2 2024 - 9:56
Takeaways from AP's report on declining condom use among younger generations - ABC News
Wednesday, October 2 2024 - 9:45
Takeaways From AP's Report on Declining Condom Use Among Younger Generations - U.S. News & World Report
Wednesday, October 2 2024 - 9:40
Pharmalittle: We're reading about a Blue Cross California deal for Humira, Gilead licensing an HIV drug, and more - STAT
Wednesday, October 2 2024 - 9:38
Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug - STAT
Wednesday, October 2 2024 - 9:13
Gilead Licenses Long-Acting HIV Prevention Drug to Generics Firms - Bloomberg
Wednesday, October 2 2024 - 8:35
Gilead Sciences (GILD) Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countri - StreetInsider.com
Wednesday, October 2 2024 - 8:33
Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries - Business Wire
Wednesday, October 2 2024 - 8:30
HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study - BMC Public Health
Wednesday, October 2 2024 - 5:22
National Latinx AIDS Awareness Day - HIV.gov
Wednesday, October 2 2024 - 3:00
Defining the Goals of HIV Science Through 2034 - HIV.gov
Wednesday, October 2 2024 - 3:00
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries - Reuters
Wednesday, October 2 2024 - 3:00
Cempa Community Care launches initiative to tackle HIV in homeless communities - Chattanooga Times Free Press
Tuesday, October 1 2024 - 21:00
R.I.P. Author Tom Spanbauer, Who Wrote of Gay Life, Family and HIV - POZ
Tuesday, October 1 2024 - 19:57
AIDS Walk Delaware continues international effort - CapeGazette.com
Tuesday, October 1 2024 - 14:08
New HIV data shows 2030 goal in jeopardy for Wales - Terrence Higgins Trust news
Tuesday, October 1 2024 - 13:03
Progress To End AIDS In Georgia ‘Threatened’ By New Anti-LGBTQ+ Law - Health Policy Watch
Tuesday, October 1 2024 - 12:17
Alarm as HIV soars by a third in heterosexual Brits in just one year... and the intriguing reasons why - Daily Mail
Tuesday, October 1 2024 - 12:08
Rise in HIV cases is ‘steepest’ among heterosexual men and women with 30% surge in 2 years... - The US Sun
Tuesday, October 1 2024 - 12:03
Promising tuberculosis therapy safe for patients with HIV, finds study - Medical Xpress
Tuesday, October 1 2024 - 12:00
Optimization of second-line and third-line antiretroviral therapy for people living with HIV - World Health Organization (WHO)
Tuesday, October 1 2024 - 9:59
Illinois HIV Care Connect’s Women and HIV Campaign Focuses on Often-Overlooked Group - Business Wire
Tuesday, October 1 2024 - 9:00
Aim to stop HIV transmission ‘in jeopardy’ after rise in cases - The Independent
Tuesday, October 1 2024 - 7:55
Elation and dismay over Gilead’s HIV drug - Down To Earth Magazine
Tuesday, October 1 2024 - 5:32
Lenacapavir: A new ally for HIV/AIDS prevention in Africa - DW (English)
Tuesday, October 1 2024 - 4:22
HIV prevention drug remains out of reach for many in Japan despite approval - The Japan Times
Tuesday, October 1 2024 - 3:45
NEW: Medicare Part B Coverage of Pre-exposure Prophylaxis (PrEP) for HIV Prevention - HIV.gov
Tuesday, October 1 2024 - 3:00
Migrants fuel surge in HIV cases to 15-year high - The Telegraph
Tuesday, October 1 2024 - 3:00
Pagination
First page
« First
Previous page
‹‹
…
Page
27
Page
28
Page
29
Page
30
Current page
31
Page
32
Page
33
Page
34
Page
35
…
Next page
››
Last page
Last »